EUCTR2009-011541-24-HU进行中（未招募）1 期
An Open-Label, Multi-Center, Follow-Up Study Designed to Evaluate the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects who Participated in the ADAGIO Study - ADAGIO Follow-Up
Teva Pharmaceutical Industries Ltd0 个研究点目标入组 700 人开始时间: 2009年6月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •1)Subjects who participated in the ADAGIO study, and who entered the active phase of the study and
- •2)Subjects who are currently on rasagiline treatment (or subjects who have stopped rasagiline treatment, are willing to restart treatment, and in the opinion of the investigator will gain clinical benefit from restarting treatment) and
- •3)Subjects with a diagnosis of Parkinson’s disease and
- •4)Subjects willing and able to give written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1)Subjects who have discontinued rasagiline treatment due to an adverse event and have not restarted rasagiline treatment subsequently.
- •2)Subjects who cannot be given rasagiline due to any exclusion based on the local label (including pregnancy or nursing women) or due to the use of medications contraindicated for concomitant use with rasagiline according to local label
- •3)Subjects with a medical condition that is considered by the investigator as significant enough to prevent participation
研究者
相似试验
进行中（未招募）
1 期
OPEN-LABEL EXTENSION and FOLLOW-UP of STUDY IN 11 004MedDRA version: 20.0 Level: HLT Classification code 10034005 Term: Parkinson's disease and parkinsonism System Organ Class: 100000004852EUCTR2015-003513-24-SKIntec Pharma, Ltd.266
进行中（未招募）
1 期
OPEN-LABEL EXTENSION and FOLLOW-UP of STUDY IN 11 004MedDRA version: 20.0 Level: HLT Classification code 10034005 Term: Parkinson's disease and parkinsonism System Organ Class: 100000004852EUCTR2015-003513-24-GBIntec Pharma, Ltd.266
进行中（未招募）
1 期
An Open-Label, Multi-Center, Follow-Up Study Designed to Evaluate the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects who Participated in the ADAGIO Study - ADAGIO Follow-UpMedDRA version: 9.1 Level: LLT Classification code 10013113 Term: Disease Parkinson'sParkinson's DiseaseEUCTR2009-011541-24-FRTeva Pharmaceutical Industries Ltd700
招募中
4 期
An Open-Label, Multi-Center, Follow-Up Study Designed to Evaluate the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects who Participated in the ADAGIO StudyParkinson's diseaseParkinson10028037NL-OMON36779TEVA Pharma7
进行中（未招募）
不适用
An Open-Label, Multi-Center, Follow-Up Study Designed to Evaluate the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects who Participated in the ADAGIO Study - ADAGIO Follow-UpParkinson's DiseaseEUCTR2009-011541-24-DETeva Pharmaceutical Industries Ltd700